New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Generate Biomedicines, Inc. (GENB) vs LB Pharmaceuticals Inc (LBRX)
- Generate Biomedicines, Inc. GENB 10.02 −3.47%
- LB Pharmaceuticals Inc LBRX 38.90 −2.80%
Generate Biomedicines, Inc. and LB Pharmaceuticals Inc are both Biotechnology companies. Generate Biomedicines, Inc. and LB Pharmaceuticals Inc are of similar size ($1.3B and $1.3B). LB Pharmaceuticals Inc has the higher net margin (0.00% vs −1,326.8%) and the lower return on invested capital (−686.2% vs 0.00%). Across the 13 metrics below, LB Pharmaceuticals Inc leads on 10 and Generate Biomedicines, Inc. on 3.
Valuation
Profitability
| Metric | GENB | LBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (1,382.04%) | 0.00% | 0.00% |
| Net margin | (1,326.75%) | 0.00% | 0.00% |
| Free cash flow margin | (1,199.36%) | 0.00% | 0.00% |
| Return on equity | 1,047.66% | (38.80%) | (51.58%) |
| Return on assets | (54.06%) | (36.48%) | (45.91%) |
| Return on invested capital | 0.00% | (686.18%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack